Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 2
2018 2
2019 1
2020 1
2021 3
2022 4
2023 1
2024 2
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
Padmapriyadarsini C, Oswal VS, Jain CD, Mariappan MV, Singla N, Kumar S, Daniel BD, Dave JD, Vadgama P, Ramraj B, Kant S, Bhatnagar AK, Shanmugam S, Paul D, Bharathi J, Palav M, Shah NV, Santhanakrishnan R, Dewan RK, Shekh N, Rathinam P, Sisara AB, Mankar SD, Bajpai J, Mittal U, Chauhan S, Kumar R, Parmar M, Mattoo SK, Jaju J; modified BPaL (mBPaL) Study Team. Padmapriyadarsini C, et al. Among authors: ramraj b. Clin Infect Dis. 2024 Dec 17;79(6):1375-1385. doi: 10.1093/cid/ciae388. Clin Infect Dis. 2024. PMID: 39194339 Clinical Trial.
Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid.
Daniel BD, Shanmugam S, Mehta R, Bhalla M, Mariappan M, Ramraj B, Awasthi AK, Patel P, Jain A, Jain P, Kumar C, Oswal V, Singla N, Kumar S, Dave J, Vadgama P, Bhatnagar AK, Kant S, Prabhakaran R, Tamakuwala G, Mukherjee RN, Santhanakrishnan RK, Ravikumar D, Nagarajan NK, Kumaravadivelu S, Bharathi J, Sridhar A, Ramachandran R, Matoo SK, Ponnuraja C, Jaju J, Padmapriyadarsini C. Daniel BD, et al. Among authors: ramraj b. J Infect. 2025 Jul;91(1):106509. doi: 10.1016/j.jinf.2025.106509. Epub 2025 May 15. J Infect. 2025. PMID: 40381662 Free PMC article. Clinical Trial.
Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant/non-responsive multidrug-resistant pulmonary tuberculosis: study protocol.
Padmapriyadarsini C, Devaleenal B, Ponnuraja C, Ramraj B, Singla R, Parmar M, Mattoo S, Mandal S. Padmapriyadarsini C, et al. Among authors: ramraj b. BMJ Open. 2022 Aug 29;12(8):e058606. doi: 10.1136/bmjopen-2021-058606. BMJ Open. 2022. PMID: 36038181 Free PMC article.
Clinico-demographic profile of pre-extensively drug-resistant pulmonary tuberculosis patients in India.
Daniel BD, Muthuvijayalakshmi M, Oswal V, Jain CK, Singla N, Kumar S, Bhatnagar A, Vohra V, Dave J, Bhui NK, Solanki R, Sridhar R, Vadgama P, Suryakant, Prabhakaran R, Ramesh PM, Jeyadeepa B, Kumaravadivelu S, Ramraj B, Jaju J, Padmapriyadarsini C. Daniel BD, et al. Among authors: ramraj b. Indian J Tuberc. 2025 Oct;72(4):562-565. doi: 10.1016/j.ijtb.2025.04.012. Epub 2025 Apr 30. Indian J Tuberc. 2025. PMID: 40975594
22 results